Trial intelligence / Profile preview

Tranexamic Acid for Drainage Reduction in Head and Neck Surgery

NCT00308880Phase 3Unknown

Sponsor
Taichung Veterans General Hospital
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tranexamic acid in head and neck neoplasms (HNN) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Drainage amount, Duration of drainage tube placement and 1 more. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

head and neck neoplasms (HNN)

Beyond the preview

Go deeper on NCT00308880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00308880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call